Mon-02-05-2016, 20:10 PM
(Mon-02-05-2016, 20:03 PM)jiml Wrote: I wonder who would fund it
I've been passed a bit more from one of our roving reporters.
Quote:
There was no external funding for this study, and the following authors gave the following conflict of interest.
Eissing L, Rustenbach SJ, Krensel M, Zander N and Spehr C are employees at the University Medical Center Hamburg-Eppendorf (UKE) and have no conflicts of interest to declare. Augustin M has served as consultant and/or paid speaker for and/or has received research grants and/or honoraries for consulting and/or scientific lectures for and/or got travel expenses reimbursed and/or participated in clinical trials sponsored by companies that manufacture drugs used for the treatment of psoriasis including Abbott, Almirall, Amgen, Biogen, Celgene, Centocor, Janssen-Cilag, Leo, Medac, MSD (formerly Essex, Schering-Plough), Novartis, Pfizer (formerly Wyeth). Radtke MA has served as consultant and/or paid speaker for and/or has received research grants and/or honoraries for consulting and/or scientific lectures for and/or got travel expenses reimbursed and/or participated in clinical trials sponsored by companies that manufacture drugs used for the treatment of psoriasis including Abbott/Abbvie, Amgen, Biogen, Celgene, Hexal, Janssen-Cilag, Leo, Medac, MSD (formerly Essex, Schering-Plough), Novartis, Mundipharma, Pfizer (formerly Wyeth) and Sandoz. Naldi L has been a consultant for Janssen-Cilag, Novartis, Pfitzer, Abbvie and Menarini.
That doesn't answer you question, but it looks like the authors have some pull to possibly make it work.